Unlocking the Potential of Antibody-Drug Conjugates in Cancer Therapy

FluoSphera and Revvity Collaborate to Develop a Multiplexed Selectivity Assay for In Vitro Drug Discovery

FluoSphera secures $1 million pre-seed investment

FluoSphera S.A. is Grant Award Recipient of CHF 1.1 million from Innosuisse

ENMEDIA sat down with the FluoSphera team to discuss their company’s highly innovative drug discovery technology

The team of FluoSphera explains how our technology is used as a powerful alternat